ESC CHAT vs Residipok
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
ESC CHAT
Get instant, personalized answers to clinical questions directly from current ESC Clinical Practice Guidelines. This tool provides relevant citations and reference links, allowing for question refinement and follow-ups. It's designed for medical professionals to enhance access to guideline information.
- Instant clinical query answers
- Based on ESC Clinical Practice Guidelines
- Provides citations and reference links
- Refine questions and ask follow-ups
- Information system for medical professionals
Read full descriptionHide full description
ESC Chat provides instant and personalised answers to clinical queries, based exclusively on current ESC Clinical Practice Guidelines. Ask your guideline-related question, and ESC Chat will promptly generate the answer, providing the relevant citations and reference links from the respective full texts. You can also refine your question and ask follow-up questions. ESC Chat is an information system intended for medical professionals to help improve access to ESC Clinical Practice Guidelines and must not be used as a substitute for health care professionals’ considered advice.
Residipok
Read full descriptionHide full description
Residipok is a pocket reference for licensed healthcare professionals, trainees, and medical students of accredited health-professions programs. TWO MODULES (v0.4) • MIC Lookup Choose a bacterium and an antibiotic to see the EUCAST v16.0 (2026) Clinical Breakpoint thresholds — S, I, R bands by clinical context (systemic, meningitis, urinary, high-dose). Enter an MIC value to categorise it. Special states clearly labelled when no breakpoint is published or the organism is intrinsically resistant. Built especially for pan-resistance scenarios where every threshold matters. • ESC Guideline Reference Structured Class / Level of Evidence summaries of recent ESC cardiology guidelines, covering acute coronary syndromes, heart failure, atrial fibrillation, hypertension, endocarditis, cardiomyopathies, valvular disease, pulmonary hypertension and embolism, peripheral arterial disease, dyslipidaemia, prevention, pregnancy, syncope, supraventricular tachycardia, and more. Each recommendation card links back to the original guideline on escardio.org. IMPORTANT — REFERENCE ONLY • Residipok is NOT a medical device. • It does NOT diagnose, treat, cure, or prevent disease. • It is NOT a substitute for clinical judgement or for the original published guideline / breakpoint table. • Always verify against the current EUCAST table and the latest ESC document before clinical reporting. Requires confirmation of HCP / trainee status on first launch. Sign-in by email, Apple, or Google. Sources: EUCAST Clinical Breakpoint Tables v16.0 (2026); European Society of Cardiology Clinical Practice Guidelines (2018–2024).
Screenshots
Verdict
The clearest difference is ads: ESC CHAT at none against Residipok's shown. Residipok's advantage is update cadence (every 2 weeks vs every 3 months) and device support (3 vs 1). On price, in-app purchases and iOS requirement there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
ESC CHAT ships an update every 3 months, Residipok every 2 weeks. The most recent releases landed on October 24, 2026 and October 25, 2026 respectively.
| Parameter | ESC CHAT | Residipok |
|---|---|---|
| Price | Free | Free |
| Rating | 1.0 (1 ratings) — better | — |
| Positive reviews | 33.3% of reviews | — |
| Number of ratings | 1 — better | — |
| Update frequency | Every 3 months | Every 2 weeks — better |
| Ads | No — better | Yes |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone | iPhone, iPad, iPod — better |
| Requires iOS | 16.6 | 15.1 — better |
| Further details — not scored | ||
| Size | 80 MB | 111 MB |
| Age rating | 4+ | 17+ |
| Developer | ESC - European Society of Cardiology | Maytham Al-taan |
In-app purchases
ESC CHAT
No in-app purchases
Residipok
No in-app purchases









